Pfizer scientist speaks out on whether Covid variations will impact vaccine effectiveness

featured image

In the middle of concerns of whether a third dosage will be required, Pfizer VP and primary clinical officer Phil Dormitzer informs NBC News’ Miguel Almaguer “we do not yet have proof” that the vaccine requires to be altered. Feb. 18, 2021

Find Out More

http://covid19globalcases.com/pfizer-scientist-speaks-out-on-whether-covid-variations-will-impact-vaccine-effectiveness/

Comments